H-SLLMWITQCFL-OH

Ref. 3D-PP46399

Informação sobre produto

• Nome: H-SLLMWITQCFL-OH
• Sinónimos: NH2-Ser-Leu-Leu-Met-Trp-Ile-Thr-Gln-Cys-Phe-Leu-OH

Descrição

Peptide H-SLLMWITQCFL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SLLMWITQCFL-OH include the following: Multiepitope CD8+ T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting V Dutoit , RN Taub, KP Papadopoulos - The Journal of , 2002 - Am Soc Clin Investighttps://www.jci.org/articles/view/16428 Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination Q Chen , H Jackson, M Shackleton , P Parente - Cancer Immunity, 2005 - AACRhttps://aacrjournals.org/cancerimmun/article-abstract/5/1/5/471995 Immune recognition of cancer-tumor antigens P Robbins - Tumor Immunology. London: Taylor & Francis, 2002 - api.taylorfrancis.comhttps://api.taylorfrancis.com/content/chapters/edit/download?identifierName=doi&identifierValue=10.1201/b12622-8&type=chapterpdf NY-ESO-1 Protein Formulated in ISCOMATRIX Adjuvant Is a Potent Anticancer Vaccine Inducing Both Humoral and CD8+ T-Cell-Mediated Immunity and Protection against NY E Maraskovsky, S Sjölander, DP Drane - Clinical cancer , 2004 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/10/8/2879/185185 humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide E Jager, YT Chen , JW Drijfhout, J Karbach - The Journal of , 1998 - rupress.orghttps://rupress.org/jem/article-abstract/187/2/265/7398 Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine D Valmori, V Dutoit , M Ayyoub, D Rimoldi, P Guillaume - Cancer immunity, 2003 - AACRhttps://aacrjournals.org/cancerimmun/article-abstract/3/1/15/472284 Cancer/testis antigens: structural and immunobiological properties AF Kirkin, KN Dzhandzhugazyan, J Zeuthen - Cancer investigation, 2002 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1081/CNV-120001150 Recognition of human tumours: cancer/testis antigens AF Kirkin, KN Dzhandzhugazyan, J Zeuthen - Cancer Immunology, 2001 - Springerhttps://link.springer.com/content/pdf/10.1007/978-94-017-0963-7.pdf#page=48 Melanoma-associated antigens recognized by cytotoxic T lymphocytes AF KIRKIN, K DZHANDZHUGAZYAN, J ZEUTHEN - Apmis, 1998 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1699-0463.1998.tb00210.x

• Marca: Biosynth